All Articles

A small Finnish firm is thriving by selling a simple antidote to screen fatigue: custom paint-by-numbers. Their success reveals a deep market need.

As healthcare costs soar, one university is betting on a century-old philosophy: whole-person care. Can this model fix a system focused on transactions?

Himax's new HE Series hardware decoders are set to give robots and smart devices unparalleled 3D vision, a critical step in industrial automation and AI.

New data reveals Europe's largest companies are closing the AI gap with North America, but a dangerous divide is opening at home, leaving smaller firms behind.

New data on at-home lecanemab injections signals a major shift in Alzheimer's care, promising greater convenience and access for patients and caregivers.

Hafnia's planned CEO transition from founder Mikael Skov to insider Søren Jensen signals a masterclass in stability and a deep bet on a digital, efficient future.

The travel giant is betting on tranquility, promoting lesser-known lakes. Is this a genuine shift to slow travel or a savvy marketing play for a new niche?

Bureau Veritas divests its major Oil, Petrochemicals, and Coal unit for €470M, a pivotal move in its LEAP | 28 strategy to chase higher margins and growth.

JCDecaux's 8-year Heathrow renewal is more than a deal. It's a blueprint for the future of advertising, merging data, infrastructure, and a captive global audience.

Toobit's integration of TradingView's advanced tools into its app is more than an update—it's a signal of a systemic shift in how we interact with markets.

Allianz's latest report reveals a global insurance market shifting to Asia, with health coverage booming and geopolitical fragmentation creating new risks.

New Zealand's RealNZ is moving beyond payments, integrating Weixin's full digital suite to offer Chinese visitors a seamless, end-to-end travel experience.

A major contract for ultra-deepwater pipelines in Angola reveals more than a corporate win; it showcases the critical tech enabling a national energy strategy.

A landmark public-private partnership brings next-gen proton therapy to Portugal, ending medical exile for patients and creating a new European oncology hub.

With FDA Priority Review for its at-home therapy Enspryng, Roche is signaling a major disruption in the lucrative Thyroid Eye Disease market.

A five-year contract extension marks over two decades of collaboration between GXO and Co-op, revealing a model built on supply chain resilience and shared social values.

As the UAE and Saudi Arabia race toward a digital future, a new report reveals a hidden threat: ungoverned AI and deepfakes are outpacing security.

A new partnership between Finland's Orion Pharma and India's Shilpa Medicare aims to bring a lower-cost cancer therapy to Europe, challenging a blockbuster drug.

Salmon giant Mowi sells its challenged Canada East operations to rival Cooke Inc., signaling a major strategic retreat and consolidating the Atlantic market.

The Sanya EDITION is betting that the future of family travel isn't more shared time, but better-segmented experiences. Is this the model that finally works?